OARD1 (Gene)

Synonyms:C6orf130, ENTREZ:221443, HGNC:21257, MIM:614393, NM_001329684, NM_001329685, NM_001329686, NM_001329688, NM_001329689, NM_001329690, NM_001329691, NM_001329692, NM_001329693, NM_001329694, NM_001329695, NM_001329696, NM_145063, NP_001316613, NP_001316614, NP_001316615, NP_001316617, NP_001316618, NP_001316619, NP_001316620, NP_001316621, NP_001316622, NP_001316623, NP_001316624, NP_001316625, NP_659500, NR_138080, O-acyl-ADP-ribose deacylase 1, OARD1, TARG1, dJ34B21.3
Omim:OMIM:614393
Id:ENSG00000124596
Hgnc:HGNC:21257
Entrez:221443
Description:O-acyl-ADP-ribose deacylase 1
The protein encoded by this gene is a deacylase that can convert O-acetyl-ADP-ribose to ADP-ribose and acetate, O-propionyl-ADP-ribose to ADP-ribose and propionate, and O-butyryl-ADP-ribose to ADP-ribose and butyrate. The ADP-ribose product is able to inhibit these reactions through a competitive feedback loop. [provided by RefSeq, Jul 2016]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View OARD1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with OARD1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using OARD1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for OARD1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with OARD1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.